Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Currently we are not the targetgroup!

Currently we are not the targetgroup!

posted on Oct 06, 2009 11:12AM

If some of you are not happy with the shareprice, be patient, the time of the little shareholder will come - but not today or tomorrow.

I wrote, that the infringing companies are those which are the main target group for the last two PR-news.

But there is another target group which I'm sure Mr. Goerner is heading for with Ibis and Imperial: Investors, who want to have a bigger piece of the cake, at a premium purchasing price, therefore holding longer and giving the stock stability for the (hopefully) strong runs in the next years.

If I was PTSC/Ibis/Imperial I'd have prepared some investor packages for these Investors: For those, who invest before the recerts of the '336, for those, who invest, before the first PDSG contracts come and so on (please don't come with "Institutional Investors are not allowed to invest in OTC or stocks under $5!" - there are many ways to invest in a company like PTSC, and there are many investors, who may and can invest).

It does not necessarily mean, that PTSC manipulates the shareprice, but together with TPL they can "steer" the market via the news - and additionally I'm still convinced this stock gets manipulated as many OTC stocks.

I don't have a problem with that, because I hope PTSC gets more than 50% long-term investors.

All IMHO - GLTA

Share
New Message
Please login to post a reply